UB-165

UB-165 is a drug which acts as an agonist at neuronal nicotinic acetylcholine receptors being a full agonist of the α3β2 isoform and a partial agonist of the α4β2* isoform. It is used to study the role of this receptor subtype in the release of dopamine and noradrenaline in the brain,^[1][2] and has also been used as a lead compound to derive a number of other selective nicotinic receptor ligands.^[3][4][5][6]

UB-165

Identifiers
IUPAC name (1R,6R)-5-(6-chloropyridin-3-yl)-9-azabicyclo[4.2.1]non-4-ene
CAS Number	200432-86-6 Y
PubChem CID	5310970
CompTox Dashboard (EPA)	DTXSID401028829
Chemical and physical data
Formula	C13H15ClN2
Molar mass	234.73 g·mol−1
3D model (JSmol)	Interactive image
SMILES c2nc(Cl)ccc2C1=CCCC3CCC1N3
(verify)